Trials
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 02/09/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
PLANEGG, GERMANY and MUNICH, GERMANY: PLANEGG, GERMANY and MUNICH, GERMANY -- (Marketwire) -- 02/02/12 -- Agennix AG (FRANKFURT: AGX) (XETRA: AGX) (ISIN DE000A1A6XX4) announced that, upon the recommendation of the study Data Safety Moni ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 02/01/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced the pricing of an underwritten public offering of 8,500,000 shares of its common stock, offered at ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 01/09/12 -- Sernova Corp. (TSX VENTURE: SVA), today announced that Dr. Philip Toleikis, Ph.D., President and CEO of Sernova, will present an update on the company& ...
WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 01/06/12 -- (NASDAQ: BASI) announced today it will make a presentation at the Sidoti & Company Semiannual Micro-Cap Conference Monday, January 9, 2012, at ...
INDIANAPOLIS, IN: INDIANAPOLIS, IN -- (Marketwire) -- 01/04/12 -- a leading contract research organization and research models and services company, announced today that has been recruited as and will join the co ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 11/15/11 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will be presenting at the foll ...
BEDFORD, MA: BEDFORD, MA -- (Marketwire) -- 10/17/11 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, , today announced the exercise of the second year contract option by the Biomedic ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 09/19/11 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced that the Company's influenza program, including its lead the ...
PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 09/14/11 -- The Medicines Company (NASDAQ: MDCO) will present at the UBS Global Life Sciences Conference on Wednesday, September 21st, in New York beginning at 8:30 ...
COLUMBIA, MD: COLUMBIA, MD -- (Marketwire) -- 09/08/11 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that Michael H. Tardugno, Celsion's President and Ch ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/02/11 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/01/11 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 08/10/11 -- (NASDAQ: CBLI) today announced that Science Translational Medicine, a leading peer-reviewed research magazine dedicated to communication and cross-fertili ...
PARSIPPANY, NJ: Independent Health Standards Organization Recommends Bivalirudin Strategy for STEMI Patients Undergoing Primary PCI ...
MINNEAPOLIS, MN: Clinical Data Published in the Journal of Alzheimer's Disease and Presented at the 2011 ICAD Meeting ...
